It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2010.
2010 | Hyderabad, Telangana, India | Struck OffHarita Drugs Private Limited, a struck off private limited company, was established on 15 February 2010 in Hyderabad, Telangana, India. Engaging in chemical products within the chemicals sector, it holds CIN: U24110TG2010PTC067022. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Harita Seeds Private Limited. It upholds a active non-compliant status. Its leadership includes Ramana Reddy Yaddala (Managing Director), Prasoona Yaddala (Additional Director). Past directors included Ramana Reddy Yaddala, Jyothirmayi Kanugonda, Amaranatha Reddy Kanugonda. Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at Flat No 216,Endicos County Apartment,D.No.7-2-1793 Alwyn Colony,(Czech Colony),Sanath Nagar, ,, Hyderabad, Telangana, 500018.
U24110TG2010PTC067022
067022
15 February 2010
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Harita Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramana Reddy Yaddala | Managing Director | 24 Jun 2010 | Current |
| Prasoona Yaddala | Additional Director | 22 Apr 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Mar 2011 | Past |
| Pramod Abcsdd | Director | 24 Jun 2010 | Past |
| Pramod Abcsdd | Director | 23 Apr 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Harita Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2016, Harita Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Harita Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Harita Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harita Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Prasoona Yaddala was appointed as a Additional Director was appointed as a Additional Director on 22 Apr 2019 & has been associated with this company since 6 years 8 months . was completed.
Progress on Harita Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was documented.
Progress on Harita Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Hyderabad. was documented.
The activity Ramana Reddy Yaddala was appointed as a Managing Director was appointed as a Managing Director on 24 Jun 2010 & has been associated with this company since 15 years 6 months . was completed.
Harita Drugs Private Limited was registered on 15 Feb 2010 with Roc Hyderabad & aged 15 years 11 months as per MCA records. was recorded as a recent event.
The CIN of Harita Drugs Private Limited is U24110TG2010PTC067022.
Harita Drugs Private Limited is headquartered at Flat No 216,Endicos County Apartment,D.No.7-2-1793 Alwyn Colony,(Czech Colony),Sanath Nagar, ,, Hyderabad, Telangana, 500018.
Harita Drugs Private Limited was incorporated on 15 February 2010.
The current directors of Harita Drugs Private Limited are
The primary industry of Harita Drugs Private Limited is Chemicals.
Harita Drugs Private Limited is unlisted.
The authorized capital of Harita Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Harita Drugs Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX